Abstract
Background
The separation of isomeric compounds from a mixture is a recurring problem in chemistry and phytochemistry research. The purification of pharmacologically active ginsenoside Rb3 from ginseng extracts is limited by the co-existence of its isomer Rb2. The aim of the present study was to develop an enzymatic elimination-combined purification method to obtain pure Rb3 from a mixture of isomers.
Methods
To isolate Rb3 from the isomeric mixture, a simple enzymatic selective elimination method was used. A ginsenoside-transforming glycoside hydrolase (Bgp2) was employed to selectively hydrolyze Rb2 into ginsenoside Rd. Ginsenoside Rb3 was then efficiently separated from the mixture using a traditional chromatographic method.
Results
Chromatographic purification of Rb3 was achieved using this novel enzymatic elimination-combined method, with 58.6-times higher yield and 13.1% less time than those of the traditional chromatographic method, with a lower minimum column length for purification. The novelty of this study was the use of a recombinant glycosidase for the selective elimination of the isomer. The isolated ginsenoside Rb3 can be used in further pharmaceutical studies.
Conclusions
Herein, we demonstrated a novel enzymatic elimination-combined purification method for the chromatographic purification of ginsenoside Rb3. This method can also be applied to purify other isomeric glycoconjugates in mixtures.
Keywords: Enzymatic elimination, Ginsenoside Rb3, Isomer, Purification, Transformation
1. Introduction
Natural products, including a vast number of glycosides, are commonly used in molecular pharmacological and medicinal chemistry studies [1]. Glycosides are composed of only a few types of monosaccharides, but the linkage stereochemistry and possible branching patterns result in diverse glycan structures and isomers [2], [3], [4]. Similar polarities and the same molecular weight make the analysis and purification of an isomeric mixture time consuming and tedious, which is also a recurring problem in chemistry [5], [6].
Ginsenosides, as triterpene saponins composed of a dammarane skeleton with several glycosylation positions, are considered pharmacologically active components in plants [7], [8]. Ginsenoside Rb3 (Rb3) is one of the major ginsenosides in ginseng and has therapeutic potential against type II diabetes, irradiation-induced skin diseases, and depression disorders [9], [10], [11], [12], [13], [14]. However, Rb3 and its isomer ginsenoside Rb2 (Rb2) normally co-exist in various parts of a ginseng plant [15], [16], [17], [18]. They are protopanaxadiol-type ginsenosides, with four sugar moieties attached at C3 and C20 positions of the aglycon are shown in Fig. 1. The only structural difference between them is the sugar moiety in the outer position of C20; Rb3 has xylopyranoside, while Rb2 has arabinopyranoside (Fig. S1). Because of structural similarity, the quantification and isolation of these two compounds from ginseng extracts are difficult. However, Rb3 showed higher pharmacological activity against skin aging than Rb2 which promote the isolation of Rb3 from the isomeric mixture [14]. Two studies have reported the separation and isolation of Rb3 by column chromatography [9], [19]. However, both the studies had limitations due to the quantification level or 10 milligram-scale preparation; thus, there is difficulty in the separation of Rb3.
Fig. 1.
Chemical structure of Rb2, Rb3, and Rd. Note that the only difference between Rb2 and Rb3 is the relative position of the hydroxyl group (Rb2, Blue; Rb3, Red).
Glycoside hydrolases (GHs, also known as glycosidases) are a group of enzymes that catalyzes the hydrolysis of glycosidic bonds between sugars or between a sugar moiety and an aglycon [20]. They increase the rate of hydrolysis by a maximum of 1017 fold compared with that by spontaneous catalysis and exhibit exquisite substrate selectivity [21]. Several attempts have been made to obtain rare minor ginsenosides from major ginsenosides using recombinant ginsenoside-transforming GHs [22], [23], [24], [25], [26]. Recently, a ginsenoside-transforming GH (Bgp2), which can hydrolyze Rb2, was reported [27]. The recombinant Bgp2 selectively hydrolyzes arabinopyranoside in Rb2 to produce ginsenoside Rd.
A mixture of Rb2 and Rb3 was separated previously from a PPD-type ginsenoside mixture (PPDGM) by traditional chromatography to purify Rb3. In the present study, we aimed to develop an enzymatic elimination-combined purification (EECP) method to obtain pure Rb3 efficiently from a mixture of isomers. After the enzymatic elimination of Rb2, pure Rb3 was efficiently separated from the Rb3 and Rd mixture by traditional chromatography.
2. Materials and methods
2.1. Materials
The PPDGM from Panax quinquefolius (Rb2, 2.8%; Rb3, 4.8%) procured from Hongjiu Biotech Co. Ltd. (Dalian, China) was used as the starting material. The solvents (methanol, ethanol, butanol, and acetonitrile) used were of HPLC grade, and other chemicals were at least of analytical reagent grade. Microbacterium esteraromaticum GS514 was aerobically cultured on nutrient agar (R2A, BD, USA) at 37°C.
2.2. Separation of the Rb2 and Rb3 mixture from PPDGM
A mixture of relatively abundant major ginsenosides, PPDGM, which can be efficiently separated from crude ginseng extracts, was used for the isolation of Rb3 [28], [29]. Previously, PPDGM has been used as a substrate for the mass production of various minor ginsenosides, such as Rg3, F2, and Rh2(S) [23], [30], [31]. From 200 g of PPDGM, 10.4 g of Rb2 and Rb3 isomer mixture was obtained, and the yield was approximately 5.2%. These results are consistent with the findings of a previous study [14]. The ginsenosides Rb2 and Rb3 account for approximately 7.6% of the PPDGM, and their mixture can be efficiently separated by Octadecyl-silica (ODS) chromatography (Fig. 2A).
Fig. 2.
HPLC analysis of purified Rb3 from the isomeric ginsenosides mixture. (A) PPDGM. (B) Rb2 and Rb3 mixture purified from PPDGM. (C) Biotransformed products of the Rb2 and Rb3 mixture by Bgp2 treatment. (D) Isolated Rb3 from the Bgp2-biotransformed product using RPHPLC. (E) Separated Rd from the Bgp2-biotransformed products.
PPDGM, PPD-type ginsenoside mixture; RPHPLC, recycling preparative HPLC.
2.3. Cloning and expression
The genomic DNA of M. esteraromaticum GS514 was extracted using a genomic DNA extraction kit (Elpis, Daejoen, Korea). The gene encoding bgp2 (GenBank accession number: JN852950) was amplified from the genomic DNA using Pfu DNA polymerase (Enzynomics, Daejoen, Korea) and the oligonucleotide primers (5′-G GTT CCG CGT GGA TCC ATG ATC CGC GAG CCC TTC CTC-3′ and 5′-G ATG CGG CCG CTC GAG CTA AGA GCC CGC GCG CAC CAA C-3′) (Macrogen Co. Ltd., Korea). The amplified DNA fragment was inserted into the linear pGEX 4T-1 vector using the EzCloning Kit (Enzynomics Co. Ltd., Korea) and transformed into E. coli DH5α. The resulting recombinant vector (pGEX-bgp2) was extracted using a plasmid extraction Kit (GeneAll Co. Ltd., Korea) and heat-shock transformed into E. coli BL21. The cells harboring pGEX-bgp2 were cultured in a shaking incubator at 37°C until the OD600 of the culture medium reached 0.6, and then protein expression was induced by the addition of Isopropyl β-D-1-thiogalactopyranoside (IPTG) at a final concentration of 0.1 mM. After culturing for a further 18 h at 18°C, the induced bacteria cells were harvested by centrifugation at 4000 × g for 15 min and were suspended and disrupted by ultrasonication.
2.4. Preparation of recombinant Bgp2 using high-cell density culture
Six grams of PPDGM were dissolved in 200 mL of 10% methanol, and the undissolved precipitants were separated. The dissolved PPDGM was subjected to liquid chromatography (C18, 120 g, 39 mm × 157 mm) and was eluted with methanol–water (4:6) mixture to yield 20 fractions. The elution was fractionated every 120 mL, and the fractions containing isomers were collected and evaporated. The separated isomeric ginsenoside mixture was characterized by HPLC.
2.5. Treatment of the Rb2 and Rb3 mixture with Bgp2
The reaction mixture consisted of the Rb2 and Rb3 mixture at the final concentration of 50 mg/mL in 200 mL of crude recombinant Bgp2 (pH 7.0). After incubation for 12 h at 37°C, the mixture was centrifuged at 4000 × g for 15 min, and then the supernatant was loaded to a column packed with HP20 resin (340 g) (Sigma, St. Louis, MO). Two liters of water were used to remove unbound hydrophilic compounds and free sugar molecules, and the absorbed ginsenosides were eluted using three bed volumes of 95% ethanol. The eluted ethanol solution with Rb3 and Rd was evaporated in vacuo to remove the ethanol.
2.6. Recycling prep-HPLC purification of Rb3 from the isomeric mixture or biotransformed products
The Rb2 and Rb3 mixture or the biotransformed product was separated by recycling preparative HPLC (RPHPLC) (LC-9210II NEXT; Japan Analytical Industry Co., Tokyo, Japan). Rb3 was separated from the mixture using a prepacked column (JAIGEL-ODS-AP-L, 20 mm (i.d.) × 500 mm (l), 10 μm) purchased from Japan Analytical Industry Co. (Japan). Acetonitrile (40%) was used as the mobile phase, and the flow rate of RPHPLC was set at 7.0 mL/min. The sample solution was prepared by dissolving 350 mg of the crude or Bgp2-treated Rb2 and Rb3 mixture in 40% acetonitrile to a final concentration of 35 mg/mL, and 1 (Rb2 and Rb3 mixture) or 10 mL (Bgp2-treated Rb2 and Rb3 mixture) of the solution was loaded for Rb3 purification, respectively.
2.7. High performance liquid chromatography analysis
The ginsenoside samples were analyzed using an Agilent 1260 Infinity HPLC system (Agilent Co Wilmington, DE). The samples were separated on an YMC ODS C18 column (5 μm, 4.6 mm (i.d.) × 250 mm (l); YMC, Japan) at a flow rate of 0.8 mL/min. The gradient elution system consisted of water (A) and acetonitrile (B), and the following program was used: 0–5 min, 15%–30% B; 5–15 min, 30%–32% B; 15–35 min, 32%–32% B; 35–45 min, 32%–45% B; 45–60 min, 45%–50% B. The column temperature and detection wavelength were 35°C and 203 nm, respectively.
3. Results and discussion
3.1. Isolation of Rb3 from the Rb2 and Rb3 mixture by RPHPLC
Rb3 was purified from an isomeric mixture using an RPHPLC system equipped with a preparative ODS column. RPHPLC can enhance the separation of compounds by recycling the effluent sample several times over the column without increasing the length of the chromatographic column. This purification method can increase the column resolution, product purity, and yield and reduce the operation cost [32], [33]. Ten micrograms of the Rb2 and Rb3 mixture were loaded on to the RPHPLC column for separation. Our previous experiment found that more than 10 mg of loading sample can decrease the purity of Rb3. In the present study, the Rb2 and Rb3 isomers exhibited signs of resolution after 10 effective columns and were baseline-resolved after 17 effective columns (Fig. 3). The purification process required more than 8 h, yielding 2.8 mg of Rb3 with 90.8% purity; the yield was 28%. RPHPLC is generally used to separate compounds from an isomeric mixture [34], [35]. However, the same polarities of Rb2 and Rb3 make the separation difficult even by RPHPLC. Similar to the present study method, Liu et al [9] purified ginsenoside Rb3 on a milligram-scale from crude extracts by chromatography.
Fig. 3.
RPHPLC chromatogram demonstrating the resolution of the isomeric Rb2 and Rb3. Conditions: column, JAIGEL-ODS-AP-L (20 mm (i.d.) × 500 mm (l)); mobile phase: H2O (solvent A) and acetonitrile (solvent B), isocratic elution: 40% B; flow rate, 7 mL/min, detection wavelength, 203 nm; sample loading concentration of 10 mg/mL; loading volume of 1 mL.
RPHPLC, recycling preparative HPLC.
3.2. Elimination of Rb2 in the isomeric mixture
The sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis showed a strong expression of ~113.4-kDa Bgp2 protein, and the expression level of Bgp2 was similar to that reported by Quan et al [27] (Fig. 4). We also confirmed that the vector without Bgp2 did not convert Rb2 or Rb3 (Fig. S2). The cell lysate of Bgp2 exhibited arabinopyranoside hydrolyzing activity when reacted with Rb2 but did not react with Rb3 (Fig. 5). The enzyme reaction was performed using crude recombinant Bgp2 cell lysate with the isomeric mixture as the substrate at a final concentration of 50 mg/mL to transform Rb2.
Fig. 4.
SDS-PAGE analysis of the recombinant Bgp2. Lanes: M, molecular mass standard; S, supernatant of E. coli crude extract carrying pGEX-bgp2; P, precipitant of E. coli crude extract carrying pGEX-bgp2. Bgp2 is marked with an arrow.
Fig. 5.
Schematic view of the transformation pathways for Rb2 conversion into ginsenoside Rd and the related structures of the ginsenosides.
As shown in Fig. 2C, Rb2 was completely converted to Rd within 12 h after the addition of crude Bgp2 to the mixture similar with the results of Quan et al [27] reported that ginsenoside Rg3 also exists in the conversion product of Rb2; however, we did not detect Rg3 in the mixture produced. This might be because the higher concentration (9.2 mg/mL) of Rb2 reduced the conversion of Rd into Rg3. The reaction mixture was applied to HP20 macroporous resin to remove proteins, sugars, and unbound impurities. After washing, ethanol elution of the ginsenosides from the HP20 macroporous resin was carried out. The eluant was then evaporated in vacuo to obtain 8.6 g of dried mixture.
The attached glycoside in the outer position of C20 forms the isomers Rb2 and Rb3 (Fig. 1). Bgp2 can selectively hydrolyze arabinopyranoside from Rb2 but cannot react with xylopyranoside of Rb3. The hydrolyzation by Bgp2 changes Rb2 to Rd, changing the polarity and molecular weight, which was evident by the change in HPLC retention time from 0.9 to 3.0 min. (Rb2 to Rd) (Fig. 2C). This makes the purification of Rb3 more efficient.
3.3. Isolation of Rb3 from the Bgp2-treated isomeric mixture using RPHPLC
Three hundred fifty milligrams of Bgp2-treated Rb2 and Rb3 mixture were used to purify Rb3 by RPHPLC. After loading, the estimated Rb3 peak was separated directly without recycling from Rd (Fig. 6). Ginsenoside Rb3 has one more xylose than Rd; thus, they can be separated by the difference in polarity by traditional chromatography purification even without RPHPLC. The fractions were collected at 26.5–45.5 min (Rb3) and 46.5–58.5 min (Rd) and evaporated separately. The content of Rb3 and Rd produced was determined by HPLC (Fig. 2D and E). The results revealed that 164 mg of Rb3 (97.6%) and 41 mg of Rd (98.9%) were obtained (Table 1). The recovery ratio from the isomeric mixture reached 72.7% during the process. Compared with those by the traditional chromatography method, the content of purified compound increased by 58.6 times, and the time was reduced by 13.1%.
Fig. 6.
RPHPLC chromatogram showing the resolution of Rb3 and Rd. Note that these two peaks can be separated without recycling. Conditions: column, JAIGEL-ODS-AP-L (20 mm (i.d.) × 500 mm (l)); mobile phase: H2O (solvent A) and acetonitrile (solvent B), isocratic elution: 40% B; flow rate, 7 mL/min, detection wavelength, 203 nm; sample loading concentration of 35 mg/mL; loading volume of 10 mL.
RPHPLC, recycling preparative HPLC.
Table 1.
Purification scheme
| No. | Sample | Loading content (mg) | Purified product (mg) | Yield (%) | Purified purity (%) | Time (min) |
|---|---|---|---|---|---|---|
| 1 | Rb2 and Rb3 mixture | 10 | 2.8 | 40.2 | 90.4 | 505 |
| 2 | Enzymatic elimination | 350 | 164 | 72.7 | 97.6 | 66 |
Liu et al [9] harvested 18.5–25.2 mg of Rb3 from crude extracts of Panax notoginseng using a reversed-phase semi-preparative C18 column. However, the purified content and yield were six and ten times less than those by the EECP method. Furthermore, the purification of Rb3 can be achieved using the EECP method with less column length because of increased polarity difference because of the transformation of Rb2 to Rd. According to the results of the present study, the column length can be reduced to 1/17 theoretically, which can significantly reduce the cost and time of isolation.
Glycosides as monosaccharides or oligosaccharides yield many isomers in plants, thus, hindering the analysis and isolation of active compounds from natural products. Several efforts have been made recently to identify and purify glycosidic isomers from mixtures. Fouque et al [6] separated and quantified an isomeric compound in a mixture by collisional excitation by multistage mass spectrometry; carbohydrate isomers were determined using the IMS-CID-IMS-MS method [36]. However, the preparative isolation of glycosidic isomers from a mixture is usually expensive, time-consuming, and laborious.
Bgp2 exhibited specificity for arabinopyranoside but showed no affinity for xylopyranoside (Fig. 5). The recognition of sugar moieties by GHs is based on the structure of active pockets of the enzymes, and most of them exhibit specificity for a few kinds of glycosides [37], [38], [39]. The GHs are widely distributed in nature and currently represented by over 241,000 sequences classified into 133 families based on amino acid sequence similarity by the Carbohydrate Active Enzyme database [40]. Because of the varied applications in the food industry and in biofuel preparation, more glycosidases are being cloned, characterized, and utilized [41]. Exploiting their selectivity, the EECP method can also be used for analytic purposes by eliminating inseparable isomeric copartners to increase peak isolation efficiency.
4. Conclusions
The analysis and purification of isomeric glycosides are considered difficult because of similar polarities and the same molecular weight of the isomers. Ginsenoside Rb3 showed higher pharmacological potential than that of its isomer Rb2. However, these two isomers are difficult to separate, and they co-exist in ginseng. Herein, we proposed a novel EECP method to enhance chromatographic purification of Rb3 from an isomeric mixture. Bgp2 can selectively transform Rb2 into Rd, significantly increasing the yield and reducing the time and minimum column length for purification. The EECP method was found to be highly efficient and simple and was demonstrated to be effective to purify Rb3 from an isomeric mixture. Moreover, the present study provides a generic concept that is promising for the purification of glycosidic isomers from crude natural products.
Conflicts of interest
The authors have no conflicts of interest to declare.
Acknowledgments
This work was funded by the Intelligent Synthetic Biology Center of Global Frontier Project, Republic of Korea (grant number 2011-0031955).
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.jgr.2019.08.003.
Contributor Information
Sun-Chang Kim, Email: sunkim@kaist.ac.kr.
Wan-Taek Im, Email: wandra@hknu.ac.kr.
Appendix A. Supplementary data
The following are the Supplementary data to this article:
References
- 1.Grynkiewicz G., Szeja W. Synthetic glycosides and glycoconjugates of low molecular weight natural products. Curr Pharm Des. 2016;22:1592–1627. doi: 10.2174/1381612822666151211094345. [DOI] [PubMed] [Google Scholar]
- 2.Marino K., Bones J., Kattla J.J., Rudd P.M. A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol. 2010;6:713–723. doi: 10.1038/nchembio.437. [DOI] [PubMed] [Google Scholar]
- 3.Cummings R.D., Pierce J.M. The challenge and promise of glycomics. Chem Biol. 2014;21:1–15. doi: 10.1016/j.chembiol.2013.12.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Uppal S.S., Beasley S.E., Scian M., Guttman M. Gas-phase hydrogen/deuterium exchange for distinguishing isomeric carbohydrate ions. Anal Chem. 2017;89:4737–4742. doi: 10.1021/acs.analchem.7b00683. [DOI] [PubMed] [Google Scholar]
- 5.Guo X., Zhang X., Feng J., Guo Z., Xiao Y., Liang X. Purification of saponins from leaves of Panax notoginseng using preparative two-dimensional reversed-phase liquid chromatography/hydrophilic interaction chromatography. Anal Bioanal Chem. 2013;405:3413–3421. doi: 10.1007/s00216-013-6721-8. [DOI] [PubMed] [Google Scholar]
- 6.Jeanne Dit Fouque D., Maroto A., Memboeuf A. Purification and quantification of an isomeric compound in a mixture by collisional excitation in multistage mass spectrometry experiments. Anal Chem. 2016;88:10821–10825. doi: 10.1021/acs.analchem.6b03490. [DOI] [PubMed] [Google Scholar]
- 7.Leung K.W., Wong A.S. Pharmacology of ginsenosides: a literature review. Chin Med. 2010;5:20. doi: 10.1186/1749-8546-5-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Matsuura H., Kasai R., Tanaka O., Saruwatari Y., Kunihiro K., Fuwa T. Further studies on dammarane-saponins of ginseng roots. Chem Pharm Bull. 1984;32:1188–1192. [Google Scholar]
- 9.Liu C., Han J., Duan Y., Huang X., Wang H. Purification and quantification of ginsenoside Rb3 and Rc from crude extracts of caudexes and leaves of Panax notoginseng. Sep Purif Technol. 2007;54:198–203. [Google Scholar]
- 10.Wang Y., Dong J., Liu P., Lau C.W., Gao Z., Zhou D., Tang J., Ng C.F., Huang Y. Ginsenoside Rb3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats. Br J Pharmacol. 2014;171:3171–3181. doi: 10.1111/bph.12660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Oh S.J., Oh Y., Ryu I.W., Kim K., Lim C.J. Protective properties of ginsenoside Rb3 against UV-B radiation-induced oxidative stress in HaCaT keratinocytes. Biosci Biotech Bioch. 2016;80:95–103. doi: 10.1080/09168451.2015.1075862. [DOI] [PubMed] [Google Scholar]
- 12.Cui J., Jiang L., Xiang H. Ginsenoside Rb3 exerts antidepressant-like effects in several animal models. J Psychopharmacol. 2012;26:697–713. doi: 10.1177/0269881111415735. [DOI] [PubMed] [Google Scholar]
- 13.Jiang S., Miao B., Song X., Jiang Z. Inactivation of GABA(A) receptor reduces ginsenoside Rb3 neuroprotection in mouse hippocampal slices after oxygen-glucose deprivation. J Ethnopharmacol. 2011;133:914–916. doi: 10.1016/j.jep.2010.10.030. [DOI] [PubMed] [Google Scholar]
- 14.Shin S., Lee J.A., Son D., Park D., Jung E. Anti-skin-aging activity of a standardized extract from panax ginseng leaves in vitro and in human volunteer. Cosmetics. 2017;4:18. [Google Scholar]
- 15.Liu F., Ma N., He C., Hu Y., Li P., Chen M., Su H., Wan J. Qualitative and quantitative analysis of the saponins in Panax notoginseng leaves using ultra performance liquid chromatography coupled with time-of-flight tandem mass spectrometry and high performance liquid chromatography coupled with UV detector. J Ginseng Res. 2018;42:149–157. doi: 10.1016/j.jgr.2017.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wan J.B., Yang F.Q., Li S.P., Wang Y.T., Cui X.M. Chemical characteristics for different parts of Panax notoginseng using pressurized liquid extraction and HPLC-ELSD. J Pharm Biomed Anal. 2006;41:1596–1601. doi: 10.1016/j.jpba.2006.01.058. [DOI] [PubMed] [Google Scholar]
- 17.Wang H.P., Zhang Y.B., Yang X.W., Zhao D.Q., Wang Y.P. Rapid characterization of ginsenosides in the roots and rhizomes of Panax ginseng by UPLC-DAD-QTOF-MS/MS and simultaneous determination of 19 ginsenosides by HPLC-ESI-MS. J Ginseng Res. 2016;40:382–394. doi: 10.1016/j.jgr.2015.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Qu C.L., Bai Y.P., Jin X.Q., Wang Y.T., Zhang K., You J.Y., Zhang H.Q. Study on ginsenosides in different parts and ages of Panax quinquefolius L. Food Chem. 2009;115:340–346. [Google Scholar]
- 19.Guo X., Zhang X., Guo Z., Liu Y., Shen A., Jin G., Liang X. Hydrophilic interaction chromatography for selective separation of isomeric saponins. J Chromatogr A. 2014;1325:121–128. doi: 10.1016/j.chroma.2013.12.006. [DOI] [PubMed] [Google Scholar]
- 20.Sarry J.E., Gunata Z. Plant and microbial glycoside hydrolases: volatile release from glycosidic aroma precursors. Food Chem. 2004;87:509–521. [Google Scholar]
- 21.Zechel D.L., Withers S.G. Glycosidase mechanisms: anatomy of a finely tuned catalyst. Acc Chem Res. 2000;33:11–18. doi: 10.1021/ar970172+. [DOI] [PubMed] [Google Scholar]
- 22.Du J., Cui C.H., Park S.C., Kim J.K., Yu H.S., Jin F.X., Sun C.K., Kim S.C., Im W.T. Identification and characterization of a ginsenoside-transforming beta-glucosidase from Pseudonocardia sp. Gsoil 1536 and its application for enhanced production of minor ginsenoside Rg2(S) PloS One. 2014;9 doi: 10.1371/journal.pone.0096914. e96914. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kim J.K., Cui C.H., Liu Q., Yoon M.H., Kim S.C., Im W.T. Mass production of the ginsenoside Rg3(S) through the combinative use of two glycoside hydrolases. Food Chem. 2013;141:1369–1377. doi: 10.1016/j.foodchem.2013.04.012. [DOI] [PubMed] [Google Scholar]
- 24.Cui C.H., Liu Q.M., Kim J.K., Sung B.H., Kim S.G., Kim S.C., Im W.T. Identification and characterization of a Mucilaginibacter sp. strain QM49 beta-glucosidase and its use in the production of the pharmaceutically active minor ginsenosides (S)-Rh1 and (S)-Rg2. Appl Environ Microbiol. 2013;79:5788–5798. doi: 10.1128/AEM.01150-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Cui C.H., Kim D.J., Jung S.C., Kim S.C., Im W.T. Enhanced production of gypenoside lxxv using a novel ginsenoside-transforming beta-glucosidase from ginseng-cultivating soil bacteria and its anti-cancer property. Molecules. 2017;22:844. doi: 10.3390/molecules22050844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.An D.S., Cui C.H., Siddiqi M.Z., Yu H.S., Jin F.X., Kim S.G., Im W.T. Gram-scale production of ginsenoside F1 using a recombinant bacterial beta-glucosidase. J Microbiol Biotechn. 2017;27:1559–1565. doi: 10.4014/jmb.1703.03006. [DOI] [PubMed] [Google Scholar]
- 27.Quan L.H., Wang C., Jin Y., Wang T.R., Kim Y.J., Yang D.C. Isolation and characterization of novel ginsenoside-hydrolyzing glycosidase from Microbacterium esteraromaticum that transforms ginsenoside Rb2 to rare ginsenoside 20(S)-Rg3. Antonie Van Leeuwenhoek. 2013;104:129–137. doi: 10.1007/s10482-013-9933-1. [DOI] [PubMed] [Google Scholar]
- 28.Wan J.B., Zhang Q.W., Ye W.C., Wang Y.T. Quantification and separation of protopanaxatriol and protopanaxadiol type saponins from Panax notoginseng with macroporous resins. Sep Purif Technol. 2008;60:198–205. [Google Scholar]
- 29.Zhao Y., Chen B., Yao S.Z. Separation of 20(S)-protopanaxdiol type ginsenosides and 20(S)-protopanaxtriol type ginsenosides with the help of macroporous resin adsorption and microwave assisted desorption. Sep Purif Technol. 2007;52:533–538. [Google Scholar]
- 30.Siddiqi M.Z., Cui C.H., Park S.K., Han N.S., Kim S.C., Im W.T. Comparative analysis of the expression level of recombinant ginsenoside-transforming beta-glucosidase in GRAS hosts and mass production of the ginsenoside Rh2-Mix. PloS One. 2017;12 doi: 10.1371/journal.pone.0176098. e0176098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Cui C.H., Kim J.K., Kim S.C., Im W.T. Characterization of a ginsenoside-transforming beta-glucosidase from Paenibacillus mucilaginosus and its application for enhanced production of minor ginsenoside F(2) PloS One. 2014;9 doi: 10.1371/journal.pone.0085727. e85727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Teoh H.K., Sorensen E., Titchener-Hooker N. Optimal operating policies for closed-loop recycling HPLC processes. Chem Eng Sci. 2003;58:4145–4158. [Google Scholar]
- 33.Hellstén S., Siitonen J., Mänttäri M., Sainio T. Steady state recycling chromatography with an integrated solvent removal unit–Separation of glucose and galactose. J Chromatogra A. 2012;1251:122–133. doi: 10.1016/j.chroma.2012.06.047. [DOI] [PubMed] [Google Scholar]
- 34.Chen T., Li H., Zou D., Liu Y., Chen C., Zhou G., Li Y. Separation of three anthraquinone glycosides including two isomers by preparative high-performance liquid chromatography and high-speed countercurrent chromatography from. Rheum Tanguticum Maxim. Ex Balf. J Sep Sci. 2016;39:3105–3112. doi: 10.1002/jssc.201600487. [DOI] [PubMed] [Google Scholar]
- 35.Nagy G., Peng T., Kabotso D.E., Novotny M.V., Pohl N.L. Protocol for the purification of protected carbohydrates: toward coupling automated synthesis to alternate-pump recycling high-performance liquid chromatography. Chem Commun. 2016;52:13253–13256. doi: 10.1039/c6cc07584c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Gaye M.M., Kurulugama R., Clemmer D.E. Investigating carbohydrate isomers by IMS-CID-IMS-MS: precursor and fragment ion cross-sections. Analyst. 2015;140:6922–6932. doi: 10.1039/c5an00840a. [DOI] [PubMed] [Google Scholar]
- 37.Kikuchi A., Okuyama M., Kato K., Osaki S., Ma M., Kumagai Y., Matsunaga K., Klahan P., Tagami T., Yao M. A novel glycoside hydrolase family 97 enzyme: bifunctional β-l-arabinopyranosidase/α-galactosidase from Bacteroides thetaiotaomicron. Biochimie. 2017;142:41–50. doi: 10.1016/j.biochi.2017.08.003. [DOI] [PubMed] [Google Scholar]
- 38.Talens-Perales D., Gorska A., Huson D.H., Polaina J., Marin-Navarro J. Analysis of domain architecture and phylogenetics of family 2 glycoside hydrolases (gh2) PloS One. 2016;11 doi: 10.1371/journal.pone.0168035. e0168035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Vocadlo D.J., Davies G.J. Mechanistic insights into glycosidase chemistry. Curr Opin Chem Biol. 2008;12:539–555. doi: 10.1016/j.cbpa.2008.05.010. [DOI] [PubMed] [Google Scholar]
- 40.Mewis K., Lenfant N., Lombard V., Henrissat B. Dividing the large glycoside hydrolase family 43 into subfamilies: a motivation for detailed enzyme characterization. Appl Environ Microb. 2016;82:1686–1692. doi: 10.1128/AEM.03453-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Sathya T.A., Khan M. Diversity of glycosyl hydrolase enzymes from metagenome and their application in food industry. J Food Sci. 2014;79:R2149–R2156. doi: 10.1111/1750-3841.12677. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






